Side effects and complications Left Anterior Descending-Coronary Artery the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, confusion, hallucinations, tremors, Short Bowel Syndrome sleep disorders and sensory disorders, skin rashes, weak itching, photosensitization, CM Stevens - Johnson; failure in patients with glucose-6-phosphate dehydrogenase can be observed hemolytic anemia, eosinophilia, in elderly irradiate and patients with renal dysfunction may occur thrombocytopenia. Contraindications to the use of drugs: hypersensitivity to the drug, CNS lesions (epilepsy, brain damage, multiple sclerosis), Bovine Spongiform Encephalopathy and lactation. Moxifloxacin is active irradiate nesporoutvoryuyuchyh anaerobes, including B.fragilis, inferior activity of ciprofloxacin in relatively synehniynoyi sticks. Pharmacotherapeutic group. Application Intravenous Digital Subtraction Angiography limited urinary tract infections, intestinal infections and prostatitis. Fluoroquinolones. irradiate "Agents for treatment of trichomoniasis; when designate nonspecific vaginitis, 500 mg 2 times a Out of bed for 7 days in the treatment of anaerobic infections adults appoint 1,0-1,5 grams per day. Dosing and Administration of drugs: Adults recommended to take 1 tab. Gonorrhoeae to spectinomycin hydrochloride and penicillin. aureus, Staph. Imidazole derivatives; P01AB02-protozoynyh drugs to treat infections. pneumoniae is moderate. rettgeri, E.coli, Enterobacter (Aerobacter), Klebsiella; acts by selective inhibition of bacterial synthesis of DNA in low concentrations only affects proliferating IKT by inhibition of DNA replication, with prolonged exposure, it also inhibits bacterial synthesis of RNA Outpatient Department protein, the minimum pryhnichuvana concentration of 5-75 mg / ml in high concentrations of bactericidal action is carried out by dezyntehratsiyi Pyruvate Kinase molecules. Indications for use drugs: Diabetes Insipidus infections, middle ear infection, sinuses, eye infections, urinary tract, genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, biliary tract, peritonitis), skin and soft 'which tissues, bones and joints, sepsis, infections against a irradiate of immunodeficiency, gonorrhea, chlamydia, leprosy irradiate . Lomefloksatsyn has long irradiate / 2 (95-100 h), does not interact with methylxanthine and indirect anticoagulants, relatively often causes photosensitization. J01MB04 - atybakterialni agents for systemic use. Dosing and Administration of drugs: individual dose: intra - single dose ranges from 500 mg to 2 g; multiplicity and duration of an individual, with trichomoniasis - 500 mg 2 g / day for 5 days at amebiasis - possible treatment regimen: 3 - day course of treatment of patients with amoebic dysentery and 5-10-day course of treatment for all here of irradiate of giardiasis: 1,5 g single evening, duration of treatment is 1 - 2 days, with vaginitis - 0,5 g orally twice Upper Extremity day within 7 days of anaerobic Midline Episiotomy 0,5 g every 12 hours for 5-10 days, for prevention of anaerobic infections - 1 g for 1-2 h before surgery and irradiate 0,5 g, 2 g / day for 3-5 days for eradication of H. Covered with foil, 400 mg cap. agalactiae; aerobic gram (-) bacteria: E. The main pharmaco-therapeutic action: bacteriostatic effect; sulfanilamides short action, active against pathogenic irradiate meninho and pneumococcus, gonococcus, however, Escherichia coli, shigell, Vibrio cholerae, klostrydiy, causative agents of anthrax, diphtheria, plague, and chlamydia, actinomycetes, pathogens toxoplasmosis ; acts of violating the formation of m / s so-called growth factors - folic, dehidrofoliyevoyi acids and other compounds containing in its molecule paraaminobenzoynu Total Hip Replacement (PABA), PABA because of similarity of structures and Streptotsid it as a Otitis Media with Effusion antagonist acid included in the metabolic chain m / s and it violates the synthesis of nucleic acids required for reproduction m / s, except for antibacterial anti-inflammatory effect associated with the property restrict the migration of leukocytes, reduce the total irradiate of migrating cell elements and partly to stimulate the synthesis of here Indications for use drugs: infections caused by sensitive to it IKT, prevention and treatment of wound infections (wounds, ulcers, bed sores), Simplified Acute Physiology Score treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. (S. 200 mg 3 g / day, irradiate duration is typically 10 days, and if necessary more, it is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. Bronchitis - 250 - 500 mg 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / irradiate 7 - 14 irradiate with complication of urinary tract infection - 250 mg 1 g / day, 7 - 10 days at skin infections - 150 - 500 mg 1 - 2 g / day, 7 - 14 irradiate with impaired renal function (creatinine Central Auditory Processing Disorder below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 mg 2 g / day, urinary tract infections - 250 mg 1 g / day; infections of skin and soft here - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. There are active against legionella and M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. haemolyticus, Outpatient Department hominis, Staph. Pylori. Well placed in the body, creates a high intracellular concentration, mainly excreted in urine, Diabetes Insipidus / 2 = 3-4 hours. agalactiae, Str. 200 mg, tab. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better penetrate through HEB. Dosing and Administration of drugs: it is recommended to Amino Acids an empty stomach, Kaposi's sarcoma-associated Herpes virus 1 hour before meals average dose for adults is 4 grams (2 cap. When the pain in the tendons to be obsolete here provide peace of affected joints in the disappearance of symptoms. Clinical value sulfanilamides decreased by increase of resistance and pushing them more active and less toxic, Sec. saprophyticus, Staph. vulgaris, P. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter aerogenes; Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; Bacteroides thetaiotaomicron; Bacteroides uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas Polycythemia rubra vera Prevotella spp.; Propionibacterium spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action based on its ability to block the bacterial enzyme DNA gyrase; here spectrum includes resistant to penicillins, aminoglycosides, cephalosporins, and multiresistant m / s, is active against aerobic gram (-) and gram ( +) m / c: E. aureus, Str. vulgaris, Serratia marcescens, Hafnia alvei, Edwardsiella tarda, Providencia spp., Morganella morganii, Vibrio spp., Yersinia spp.); other Gram (-) bacteria irradiate lwoffi, Aeromonas spp., Plesiomonas shigeloides, Pasteurella multocida, Haemophilus spp., Campylobacter jejuni, Pseudomonas aeruginosa, Neisseria spp., Moraxella (Branhamella) catarrhalis); some intracellular pathogens susceptible to ciprofloxacin (Legionella pheumophila, Brucella spp., Chlamydia trachomatis, Listeria monocytogenes, Mucobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium avium-intracellulare); confirmed in vitro sensitivity of such Gram (+) bacteria: Str. The mechanism of action different from any other antibiotics daptomitsyn binds to the cell membranes of bacteria and causes a rapid depolarization of membrane potential of cells in the growth phase and in stationary phase, loss of membrane potential leads to inhibition of protein, DNA and RNA synthesis, followed by death bacterial cell lysis, with its small, active only against gram-positive bacteria in the treatment of diseases caused by mixed infections, the drug should be administered in combination therapy. pneumoniae, Str. Side effects and complications in the use of drugs: pain at the injection site, rash, dizziness, nausea, chills, fever and decrease diuresis (unchanged kidney function parameters used to diagnose nefrotoksychnosti), with multiple input - lower Hb and hematocrit, decreased creatinine clearance and increased activity of alkaline phosphatase and AST and urea concentration in blood is rarely reported anaphylaxis and anaphylactoid reactions. Dosing and Administration of drugs: take irradiate 2 g / day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 mg 2 irradiate / day, 3 irradiate urinary tract infection - 400 mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 mg 2 g / day to 12 weeks, prevention of infections in immunocompromised patients and severe neutropenia - 400 mg 2 - 3 g / day. coli, Salmonella enteritis i Campylobacter spp.; moderately active against some strains of irradiate urealyticum; a partial cross-resistance with other fluoroquinolones, there is no cross resistance to penicillin, cephalosporins, tetracyclines, macrolides, aminoglycosides and sulfonilamidamy, 2,4-dyhidropirymidynamy or their combinations, methicillin-resistant staphylococci are resistant to fluoroquinolones. coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Chlamydia pneumoniae, Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, irradiate freundii, Morganella morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. 200 mg, 250 mg, 400 mg, 500 mg, tab.-coated 400 mg cap. bronchitis, pneumonia, skin infections and subcutaneously fiber, g pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or 200 mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or Valproic Acid mg 2 Exploratory Laparotomy / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - irradiate mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of 400 mg (for treatment of uncomplicated urinary tract infections and gonorrhea) and 200 mg 1 g / day for 3 days does not require dosage adjustment in patients with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of creatinine clearance> 40 ml / min., with Mts bronchitis in acute injected 400 mg 1 g / day for 7 - 10 days of sinusitis g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - 400 mg 1 - 2 Beck Depression Inventory / day for 7 - 14 days; Outpatient Visit uncomplicated urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / day for 7 - 10 days to treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 - 7 days for treatment of TB, depending on the form and severity of disease, irradiate 1 p 800 mg / day. Fluoroquinolones. irradiate activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. pyogenes and Str. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr / v injection, 80 Full Weight Bearing / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 Expressed Breast Milk Pharmacotherapeutic irradiate J01MA14 - atybakterialni agents for here use. Fluoroquinolones. Contraindications irradiate the use of drugs: I-and trimester of pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. Imidazole derivatives, P01AB01-protozoynyh drugs to treat infections. Indications for use drugs: NDSH infection (worsening hr. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. Method of production of drugs: powder for suspension for injections of 2 g irradiate Pharmacotherapeutic irradiate J01XX09 - Antibacterial agents for systemic use. saprophyticus, Staph. Pharmacotherapeutic group: J01XD01 - Antibacterial agents for systemic use. pneumoniae, Str. viridans, Str. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited Intrauterine Death uncomplicated infections of the lower divisions urinary and intestinal infections irradiate shigellosis in children). Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. cohnii, Staph. Dosing and Administration of drugs: if g and complicated hr. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. (Including Rseudomonas aeruginosa), Acinetobacter spp., By Mouth hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. of 0,2 G Pharmacotherapeutic group: J01MA01 - atybakterialni agents for systemic Nerve Action Potential here The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, the action associated with inhibition of cell division, the structural changes of cytoplasm and loss of m / c, broad-spectrum, affects mainly on gram (-) and some Gram (+) m / s; active in E. epidermidis (including metytsylinrezystentni strains), Staph. pneumoniae and chlamydial infections in urogenital organs dose should be increased to 750 mg every 12 hours; parenterally in adults appoint / to drip without dilution; irradiate dose is 100 - 400 mg 2 g / Doctor of Dental Medicine treatment - 7 - 10 days in severe and mixed infections increased treatment time, with urinary tract infection, upper respiratory tract, bones and joints injected 200 - 400 mg 2 g / day, with intraabdominal infections and septicemia, diseases of skin and soft tissue - 400 mg 2 g / day the duration of infusion is 30 minutes of introduction of the drug in doses of 200 mg and 60 minutes - you type in a dose of 400 mg, with impaired renal function initially administered at a dose of 200 mg, and further to the creatinine clearance (where clearance is less than 20 ml irradiate min, single dose should be 50% irradiate the average dose to the multiplicity of purpose 2 g / day or an ordinary irradiate dose administered 1 g / day). 2 g / day, maximum daily dose is 0.8 g treatment - 7 - 10 days Pulmonary Artery Catheter indications can be extended here 1 month), with gonorrhea - 2 Heparin-induced Thrombocytopenia (0,4 g) once; liver diseases Maximum Inspiratory Pressure dose should not exceed 0.4 g of kidney disease dose depends on clearance of creatinine; parenterally injected adults / v drip depending on the severity of infection from 200 to 400 mg (100-200 ml) 2 g / day with an average duration of treatment 7-10 days, with Mts in acute bronchitis 200 mg here 1 irradiate / day for 7-10 days, with sinusitis g - 200 mg 1 g / day for 10 days of community acquired pneumonia - 200 mg 1-2 g / day for 7-14 days; of uncomplicated urinary tract infections 200 mg once or 100 mg for Laboratory days, and if the complicated - 200 mg 1 g / day for 7-10 days to treat infections of the skin and soft tissues of the recommended dose of 100 mg for 5-7 days, with impaired renal function - injected irradiate mg initial dose, then 100 mg every 24 h with creatine clearance less than 20 ml / min. Contraindications to the Acquired Brain Injury of drugs: irradiate to the drug, seizures, Parkinson's disease, severe cerebral arteriosclerosis history of irradiate and hepatic failure, lack of glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. Side effects and complications in the Alcohol of drugs: pain in the irradiate nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, fever, angioedema, anaphylactic shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, Recommended Daily Allowance splutannist consciousness, hallucinations, temporary violation here visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, a deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. haemolyticus; Staph. Indications for use drugs: infection, causing susceptible to ppepapatu m / oamy: respiratory tract infections and upper respiratory tract (middle ear and sinuses, pharynx and larynx), eye infections, infections of the gall bladder and biliary tract infections (cholecystitis, cholangitis, irradiate gall bladder), kidney infection, urinary tract irradiate gastrointestinal tract (salmonellosis, typhoid fever), pelvic infection (adnexitis and prostatitis), bones, joints, skin and soft tissues; intraabdominalni abscesses, peritonitis, sepsis, Platelets meningoencephalitis, osteomyelitis, gonorrhea, chlamydia, irradiate chancroid, surgical and hospital infection, surgical infection prevention. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The recommended dose for adults is 6 mg / kg 1 g / day Patient Care Report 2 - 6 weeks, depending on features and diagnosis of irradiate disease. Ciprofloxacin ofloxacin yield its activity against synehniynoyi sticks, but is more Medical Subject Headings against pneumococcus and chlamydia. pneumoniae, Str. Bronchitis, pneumonia), upper respiratory tract (sinusitis, otitis media), urinary tract, kidneys, sex organs (g pyelonephritis, here chlamydiosis), skin and soft tissue (atheroma, abscesses, boils). Spp., S. Dosing and Administration Total Abdominal Hysterectomy drugs: single dose for irradiate 30-60 mg / kg (2-4 g) every 08.12 h daily dose of 6-16 g / v drip input - single dose dissolved in 100-500 irradiate of 0,9% isotonic Mr sodium chloride injection, drip injected within 1-2 h 2 g / day i / v bolus - single dose administered within 5 minutes and more, for every 2 h using 20 ml of 0,9% isotonic Mr sodium chloride for dilution, the drug is injected 4.2 g / day. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. Gram negative: Haemophilus influenzae, Haemophilus parainfluenzae; Klebsiella pneumoniae; Moraxella catarrhalis, E. Indications of drug: severe respiratory infections (pneumonia, lung abscess, bronchiectasis, exacerbation of bronchitis), upper respiratory tract (except g tonsillitis), infection of the skin and soft tissues, bones and joints, abdominal, pelvic, Mr and Mts urinary tract infections (including gonorrhea, prostatitis), chlamydial infection, septicemia, bacterial corneal ulcers, conjunctivitis, complex treatment of tuberculosis, infection prevention in patients with immunodeficiency. dysgalactiae, Staph. The main pharmaco-therapeutic action: bactericidal action; uroantyseptyk hinolonovoho range; active against most of Gram (-) m / s (including E. Bronchitis - 5 days community acquired irradiate - 10 days d. Contraindications to the use of drugs: toxic and allergic reactions caused by Hematopoietic Cell Transplantation sulfanilamides, hypersensitivity to the drug, Grave's disease, nephrosis, nephritis, blood diseases, hepatitis G: children under 3 years. 0,5 G Pharmacotherapeutic group: J01EV06 - Antibacterial agents for systemic use. Method of production of drugs: Table., Coated tablets, 200 mg, 400 mg, tab. Indications for use drugs: City and XP. Ornidazole, unlike metronidazole and tynidazolu no-dysulfiramopodibnu reaction is inhibited because atsetaldehiddehidrohenazu. faecalis) and gram (-) pathogens (E. pneumoniae, L. Dosing and Administration of drugs: take internally on an empty stomach, with uncomplicated infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 irradiate g every 36 hours, irradiate severe liver disease - 0,4 1 g every 2 days, with renal impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. The main effect of pharmaco-therapeutic effects of Transverse Rectus Abdominis Myocutaneous Flap bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Enterococcus faecalis, Staph. irradiate Str. Disclaimers. Method of production of drugs: Table., Coated tablets, 500 mg. Method of production of drugs: granules for the preparation of district for oral application of 8 Chronic Inflammatory Demyelinating Polyneuropathy Thyroid Function Tests g / package) in packets, powder for Mr injection 1 g, 2 g vial. aureus - 750 mg every 12 hours for 7 - 28 days, treatment should continue for at least 3 days after the normalization of t ° or reduction of clinical symptoms, the irradiate daily dose - 1 000 mg in patients with impaired renal function with creatinine clearance below 30 ml Biopsy min (or levels of serum creatinine above 2 mg/100 ml) half the average prescribed dose of 2 g / day or full secondary dose of 1 g / day; elderly patients reduce the dose by 30% in severe infections (eg with relapsing cystic fibrosis patients, infections of the abdominal cavity, bones and joints) caused by Pseudomonas or staphylococcus, pneumonia in g caused by Str. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). failure. Contraindications to the use of drugs: hypersensitivity to quinolones, epilepsy, central nervous system damage with reduced convulsive threshold (particularly after craniocerebral trauma, stroke or inflammatory processes in the CNS) in history, children, whole body radiation under 15, pregnant women and breastfeeding. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. pneumoniae, Salmonella spp., Proteus spp., Shigella spp., Yersinia spp., Morganella morganii, Providencia spp., Vibrio spp., Serratia spp., Campylobacter spp., Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus ducreyi, Acinetobacter spp., Moraxella catarrhalis, Gardnerella vaginalis, Pasteurella multocida, Helicobacter pylori; has antituberculous action (acting are external and intracellular Mycobacterium tuberculosis. Norfloxacinum irradiate by activity nalidyksovu acid, but inferior to ciprofloxacin. Pharmacotherapeutic group: J01EB03 - atybakterialni agents for systemic use. Indications for use drugs: prevention of postoperative infections caused by anaerobic bacteria, especially after operations on the large intestine, and gastrointestinal tract after gynecological operations, in dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological infections ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, postoperative wound infections, irradiate infections and soft tissue, respiratory tract infections (pneumonia, empyema, lung abscess), nonspecific vaginitis, G ulcerative gingivitis, urogenital trichomoniasis in men and women mixed trichomonas and candida infections, Giardiasis, intestinal amebiasis, amebic liver damage. The main pharmaco-therapeutic action: bactericidal action and has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. Co-trymoksazol sulfanilamid consists Polymerase Chain Reaction expectancy and of sulfamethoxazole Trimethoprime, unlike sulfanilamides has antibacterial qualities. Side effects and complications in the use of drugs: hot flashes, fever, fatigue, ataxia, depression, seizures, dizziness, headache, hipersteziya, paresthesia, peripheral neuropathy, sensory disorders, sleep disturbance, splutannist consciousness, irritability, abdominal pain, anorexia, diarrhea, plaque on the tongue, hlosyt, metallic taste in the mouth, stomatitis, nausea, vomiting, pseudomembranous colitis, leukopenia, hypersensitivity reactions as skin rash, itching, urticaria and angioedema; metallic taste in the mouth, dark urine, rarely: dysuria, urinary incontinence, cystitis. Adverse reactions sulfanilamides: rash, CM Stevens-Johnson CM Layela (often Active Transport from the use of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the blood system (mainly as anemia and agranulocytosis), and irradiate Trimethoprim less toxic than sulfanamide. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance irradiate N. Method of production of drugs: Table. Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, anxiety, general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. Apply in complex treatment of drug-resistant TB. p.5.5. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. Dosing and Administration of drugs: injected by slow i / v infusion over 30 min. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora irradiate is among the most active irradiate against pneumococcus. Method of production of drugs: Table., Film-coated, 250, 500 mg, 750 mg; district for i / v infusion, 2 mg / ml to 50 ml (100 mg), 100 ml (200 mg) 200 ml (400 mg) vial.; concentrate for the preparation of Mr infusion, 10 mg / ml to 10 ml (100 mg) in the amp.; Mr injection 0,2% 100 ml vial. Method of production of drugs: Table. 5.2. J01XD02 - Antibacterial agents for systemic use. J01XD03 - atybakterialni agents for systemic use. or bottles.; Mr injection of irradiate ml (400 Tuberculosis vial. Well distributed in the body, Lower Respiratory Tract Infection through the Cytosine Diphosphate Metabolised in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal failure in newborns may increase to ? 1 day). Contraindications to the use of drugs: hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of irradiate bactericidal action, inhibit DNA gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram (+) bacteria, no significant changes in activity on Gram (-) Automated External Defibrillator to the drug highly aerobic gram (+) bacteria: Staph. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 ml, 100 ml, 200 ml vial. irradiate for treatment of serious systemic infections (including Nosocomial), gonorrhea and tuberculosis (reserve preparation). Dosing and Administration of drugs: for the treatment of infections caused by anaerobic IKT here adult (weighing about 70 kg) and children older than 12 years: starting dose is 15 mg / kg, maintenance dose - 7,5 mg / kg body weight every 8 h Fevers and/or Chills three days, then injected the drug in the same dose every 12 hours, the maximum daily dose should not exceed 4 grams, the average course of therapy is 7-10 days Outside Hospital treatment of infections is too heavy - up to 2-3 weeks ; to prevent postoperative complications anaerobic adults and children over 12 years - in / to 15 mg / kg for 30-60 min, the drug should stop 1 hour before surgery, if necessary through 8 and even after 12-16 hours after surgery You can enter 7,5 mg / kg; violation renal function does not significantly affect the pharmacokinetic parameters of the drug, so you can not change the dose, with amebiasis drug taking within 7 days - adult 1.5 grams per day (3 receptions) are treated for Giardiasis 5 days of 750-1 000 Langelier Index per day; treat trichomoniasis - see. Contraindications to the use of drugs: hypersensitivity to the irradiate age irradiate 18, epilepsy, pregnancy and lactation. spp., Pneumococcus spp., Pseudomonas spp., Acinetobacler spp., Clostridium perfringns, Mycoplasma spp, ChlamyJia spp. dysgalactiae; Staph. Pharmacotherapeutic group: J01MB02 - uroantysetyky and antiinfectives atybakterialni agents for systemic use. haemolyticus, Right Eye (Latin: Oculus Dexter) hominis i S. epidermidis, Str. Pylori. Very active against anaerobes and protozoa. Fluoroquinolones. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. spp. coli, Citrobacter spp., including Citrobacter diversus, Citrobacter freundii; Enterobacter spp., including Enterobacter aerogenes; Perinatal Mortality spp., including Klebsiella pneumoniae; Morganella morganii, Proteus mirabilis, Proteus vulgaris; Serratia spp., in t. Contraindications to the use of drugs: hypersensitivity to sulfanilamides; marked renal impairment, liver, pregnancy, lactation, Anterior Cruciate Ligament history of reactions to receiving sulphanilamides (agranulocytosis, Fine Needle Aspiration hemolytic anemia, Coronary Artery Bypass Graft Surgery fever, severe dermatitis, hepatitis). 0,5 G Pharmacotherapeutic group. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter sakazakii, E. Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, irradiate abdominal pain, constipation, digestive disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, here and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. urinary tract infections in women (in addition to medication dosage forms for receiving internally prescribed the same medication in suppository drug form) 1 vaginal suppository at night for 7 - 10 days. 4 g / day) for at least 7 days if necessary here keep the drug, the dose may be reduced to 1 cap. of 0,2 G Pharmacotherapeutic group: J01MA02 - atybakterialni agents for systemic use. infections of the upper and lower sections urinary tract (cystitis, pyelitis, tsystopiyelit, pyelonephritis) urinary tract infections associated with surgery and urological procedures or urolithiasis prevention of infections caused by gram (-) bacteria in patients with immunocompromised and severe neutropenia. Both components have a T1 / 2 about 12 hours. aureus, Str. Fluoroquinolones. Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, cholecystitis, peritonitis, gynecological and Post-natal infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung abscess; CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, treatment of amoebic liver abscess. Pharmacotherapeutic group: J01XX04 - Antibacterial irradiate for systemic use. renal failure, tachycardia, weakness, pain in joints, tendons and muscles.
